Skip to main content
. 2019 Apr 9;2019:7475151. doi: 10.1155/2019/7475151

Table 2.

The incidence of adverse reactions between the treatment group and control group.

treatment group (n=1669) control group (n=1664)
blood pressure elevation 24 (1.44%) 38 (2.23%)
facial flushing 22 (1.32%) 30 (1.80%)
nausea and vomiting 29 (1.74%) 82 (4.93%)
abdominal discomfort 5 (0.30%) 7 (0.42%)
chest discomfort 15 (0.90%) 34 (2.04%)
arrhythmia 11 (0.66%) 20 (1.20%)
allergic reaction 1 (0.06%) 0 (0.00%)